The company is entering mehq and guiacol through anisole route. This has only been achieved by clean science so far who took share away from hq based producers. Does anyone have a sense on the economics vol can generate on these products? Clean science does north of 40 pc ebitda here.
Secondly with hq prices declining, have players using this route of manufacturing become competitive again? The price of hq had gone to 13-15 usd vs 10 usd price of mehq ans approx 5 for guaiacol. Hq prices are down to 7 usd now which makes such players viable again.
Subscribe To Our Free Newsletter |